Cytogenetic Study of Ocular Melanoma

Status Completed

Clinical Trial Summary

Patients who are diagnosed with choroidal melanoma and undergo I-125 plaque or enucleation surgery consent to participate in the study. A tumor sample taken during surgery is studied in the lab for genetic features. These features and features of subjects' clinical course are recorded. Analysis of the data may identify genetic features that are indicative of prognostic factors including risk of metastasis.

Clinical Trial Description

The Jules Stein Eye Institute Ocular Melanoma Research Group is conducting cytogenetic studies of choroidal melanoma to improve the screening of biopsy samples of choroidal melanoma through cytogenetic analysis. Our goal is to identify molecular probes that specifically target regions of chromosomes that undergo changes characteristic of metastatic choroidal melanoma. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00344799
Study type	Observational
Source	Jonsson Comprehensive Cancer Center
Contact
Status	Completed
Phase
Start date	January 8, 2005
Completion date	October 23, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00680225` - Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma	Phase 3
Completed	`NCT00750399` - Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma	Phase 1
Recruiting	`NCT03941379` - A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
Completed	`NCT02875652` - Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)	N/A
Completed	`NCT00765921` - Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma	Phase 1
Completed	`NCT00351728` - Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone	N/A
Completed	`NCT01460810` - Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal Melanoma	N/A
Completed	`NCT01251978` - Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)	Phase 2
Completed	`NCT01253759` - Long Term Results of Combined Transpupillary Thermotherapy (TTT) Indocyanine Green (ICG) Based Photodynamic Therapy (PDT) in Choroidal Melanoma	Phase 4
Completed	`NCT03052127` - Study in Subjects With Small Primary Choroidal Melanoma	Phase 1/Phase 2
Active, not recruiting	`NCT00111046` - Pain Relief - Tramadol Versus Ibuprofen	Phase 1/Phase 2
Recruiting	`NCT06007690` - A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma	Phase 3
Active, not recruiting	`NCT04417530` - Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma	Phase 2
Terminated	`NCT05266430` - Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)